Prescribing Smart Aging: Integrating Health Systems With Community-Based Lifestyle Interventions



Status:Enrolling by invitation
Conditions:Healthy Studies, Healthy Studies
Therapuetic Areas:Other
Healthy:No
Age Range:65 - Any
Updated:11/24/2018
Start Date:July 1, 2018
End Date:June 1, 2021

Use our guide to learn which trials are right for you!

The purpose of this study is to test the efficacy of delivering an exercise and healthy
lifestyle program, Smart Aging, to older adults.

The Smart Aging Program is designed to be scalable, implementable, and sustainable in the
real world. This program joins patients and their clinicians with community-based fitness
centers. The Smart Aging Program looks to use already existing resources to deliver an
innovative program to increase physical activity in older adults.

The program begins at the patient-physician level. The program is conducted in
community-based fitness centers, the participant's home (home exercise, monitoring) and also
sends physical activity data back to the clinician using mobile technology.

The Smart Aging Program consists of a personalized and structured exercise program combined
with lifestyle education and mobile-health monitoring. The exercise program includes a
12-week initiation phase, followed by a 40-week maintenance phase.

Inclusion Criteria:

- Clinician referred

- Ambulatory: walk unassisted and successfully complete the 6 minute walk test without
rest

- Sufficiently fluent in English to participate in study procedures

- Sedentary or underactive by the Telephone Assessment of Physical Activity61

Exclusion Criteria:

- Clinically-significant systemic or psychiatric illness that may affect safety or
completion

- Diagnosis of dementia; use of dementia medications (cholinesterase inhibitors,
memantine)

- Myocardial infarction or unstable coronary artery disease (e.g., angina, arrhythmia)
in last 6 months.

- Cerebrovascular event (stroke or transient ischemic attack) in the last 6 months

- Cancer diagnosis in the last 2 years (except non-metastatic basal or squamous cell
carcinoma or cancer in remission in the absence of treatment for at least 2 years)

- Significant pain or musculoskeletal disorder limiting the ability to participate
safely

- Another member of the household enrolled in the study
We found this trial at
1
site
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials